Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05675865 · ClinicalTrials.gov registry record · NA

Cryoablation for Monomorphic Ventricular Tachycardia

A NA study of Sustained VT, sponsored by Adagio Medical.

Recruiting
Registry status
NA
Development phase
206
Enrollment target
15
Study locations

NCT05675865 is a NA study of Sustained VT that is actively recruiting participants, run by Adagio Medical. The registered enrollment target is 206 participants. The trial reports 15 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05675865, a NA study of Sustained VT, is actively recruiting participants, sponsored by Adagio Medical.

RECRUITING
Registry status
NA
Development phase
206 participants
Enrollment target
15
Study locations

Study Summary

The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)

Conditions Studied

Interventions

  • DEVICE cryoablation procedure

Study Locations (15)

New York

  • Icahn School of Medicine at Mount Sinai - New York
  • Weill Cornell Medical Center - New York
  • Northwell Health- Staten Island University Hospital - Staten Island

Quebec

  • Montreal Heart Institute - Montreal
  • McGill University - Montreal

Arizona

  • Banner University Medical Center Phoenix - Phoenix

California

  • University of California San Francisco - San Francisco

Maryland

  • Johns Hopkins University - Baltimore

Massachusetts

  • Brigham and Women's Hospital - Boston

Michigan

  • University of Michigan - Ann Arbor

Ohio

  • Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 206 participants
Start Date 2023-09-11
Est. Completion 2026-03-30
Phase NA

Sponsor

Adagio Medical

3 total trials

What the Registry Record Tells You About NCT05675865

The ClinicalTrials.gov registry entry for NCT05675865 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Adagio Medical, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sustained VT appearing as the primary indexed condition, and to 1 intervention - of which cryoablation procedure is the first listed.

NCT05675865 reports 15 study locations spanning 12 distinct geographic areas - top geographies include New York, Quebec, Arizona.

Frequently Asked Questions

What is clinical trial NCT05675865 about?

NCT05675865 is a clinical study titled "Cryoablation for Monomorphic Ventricular Tachycardia". The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)

What is the current status of trial NCT05675865?

This trial is currently recruiting. It is a NA study. The enrollment target is 206 participants. The study started on 2023-09-11. Estimated completion is 2026-03-30.

What conditions does trial NCT05675865 study?

This clinical trial studies the following conditions: Sustained VT.

What interventions are being tested in trial NCT05675865?

The interventions under investigation include: cryoablation procedure (DEVICE).

Who is sponsoring clinical trial NCT05675865?

This trial is sponsored by Adagio Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05675865 being conducted?

This trial has 15 study locations across Arizona, California, Maryland, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sustained VT

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.